期刊文献+

血管舒缓素对PDGF诱导的大鼠血管平滑肌细胞增殖的影响 被引量:4

Effect of kallikrein on PDGF induced proliferation of cultured rat aortic vascular smooth muscle cells
下载PDF
导出
摘要 目的探讨了血管舒缓素对血小板趋化生长因子(PDGF)诱导培养的大鼠胸主动脉平滑肌细胞增殖的影响。方法取SD大鼠胸主动脉平滑肌细胞进行培养,传至5代后,分组观察PDGF、PDGF+血管舒缓素组、PDGF+血管舒缓素+缓激肽受体拮抗剂组等。干预因素作用于血管平滑肌细胞(VSMC),对3H胸腺嘧啶(3HTdR)的掺入及原癌基因cmycmRNA表达的影响。结果1.PDGF可促进VSMC3HTdR的掺入和cmycmRNA表达,这种表达在2小时时达高峰。2.血管舒缓素可抑制PDGF诱导的VSMC3HTdR的掺入和cmycmRNA表达,这种抑制作用可被缓激肽受体拮抗剂所阻断。结论血管舒缓素可抑制PDGF诱导的VSMC增殖作用。 Objective The purpose of the present study was to explore the effect of Kallikrein on PDGF induced proliferation of rat aortic vascular smooth muscle cells (VSMC).Methods In vitro cultured rat aortic VSMC model was established. Cells of 4 6 passages were used for the experiment. At was divided into four groups: (1). Control; (2). PDGF (50ng/ml); (3). PDGF+Kallikrein(10u/ml); (4).PDGF+Kallikrein+Bradykinin receptor antagonist HOE140(10 -4 M). Proliferation of VSMC in culture was measured by 3H TdR incorporation into cell DNA. The expression of VSMC c myc mRNA was determined by using the RT PCR technique.Results (1). Compared with the control, PDGF significantly increased the 3H TdR incorporation and the expression of c myc mRNA in cultured VSMC, and the expression of c myc mRNA peaked at 2h (P<0.05). (2). The action of PDGF was inhibited by kallikrein. The effect of kallikrein on PDGF can be blocked by HOE140.Conclusion These results suggest that kallikrein can inhibit the proliferation of cultured VSMC induced by PDGF.
出处 《上海医学》 CAS CSCD 北大核心 1999年第2期112-114,共3页 Shanghai Medical Journal
基金 上海市卫生局青年科研基金
关键词 血管舒缓素 血管平滑肌细胞 冠心病 PDGF 大鼠 Kallikrein PDGF Rat aortic vascular smooth muscle cells c myc mRNA
  • 相关文献

参考文献3

共引文献16

同被引文献60

  • 1脑卒中患者临床神经功能缺损程度评分标准(1995)[J].中华神经科杂志,1996,29(6):381-383. 被引量:15727
  • 2孟家眉.对脑卒中临床研究工作的建议[J].中华神经精神科杂志,1988,21:57-58.
  • 3Bhoola KD,Figueroa CD,Worthy K.Bioregulation of kinins:kallikreins,kininogens,and kininases.Pharmacol Rev,1992,44(1):1-80.
  • 4Cloutier F,Couture R.Pharmacological characterization ofthe cardiovascular responses elicited by kinin B1 and B2 receptor agonists in the spinal cord of streptozotocin diabetic rats.Br J Pharmacol,2000,130 (2):375-385.
  • 5Diamandis EP,Yousef GM.Human tissue kallikreins:a family of new cancer biomarkers.Clin Chem,2002,48(8):1198~1205.
  • 6Rhaleb NE,Yang XP,Nanba M,et al.Effect of chronic blockade of the kallikrkinin system on the development of hypertension in rats.Hypertension,2001,37 (1):121-128.
  • 7Marceau F,Hess JF.The B1 receptors for kinins.Pharmacol Rev,1998,50:357-386.
  • 8Marcondes S,Antunes E.The plasma and tissue kininogen-kallikrein-kinin system:role in the cardiovascular system.CurrMed Chem Cardiovasc Hematol Agents,2005,3:33-44.
  • 9Chen VC,Chao L,Chao J.Roles of the P1,P2,and P3 residues in determining inhibitory specificity of kallistatin toward human tissue kallikrein.J Biol Chem,2000,275:38457-38466.
  • 10Ding-Zhou L,Margaill I,Palmier B.LF 16-0687 Ms,a bradykinin B2 receptor antagonist,reduces ischemic brain in jury in a murinemodel of transient focal cerebralischemia.Br J Pharmacol,2003,139:1539-1547.

引证文献4

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部